
21 Oct Blog| FDA 510(k) Exemption Guidance in 2026: What MedTech Companies Need to Know
The FDA’s 2026 update to its 510(k) exemption guidance may create new opportunities for certain medical device manufacturers planning to enter the U.S. market. | But what does this mean for MedTech OEMs?
The FDA’s 510(k) pathway requires manufacturers to demonstrate that their medical device is substantially equivalent to a legally marketed device. However, certain devices are exempt from this premarket notification requirement.
The FDA has outlined its intention to exempt certain unclassified medical device types from 510(k) premarket notification requirements. Manufacturers should verify whether an exemption has formally taken effect and whether their specific device meets the applicable conditions and limitations. Eligibility depends on the device and its applicable regulatory requirements.
RECENT POSTS
For manufacturers whose devices qualify for exemption, the update may reduce regulatory workload and associated costs, potentially simplifying aspects of U.S. market-entry planning.
Three considerations are particularly important:
- Review your regulatory pathway. Verify the applicable device classification, product code and exemption criteria.
- Reassess timelines and costs. Where a 510(k) submission is not required, companies may be able to reduce preparation costs and simplify regulatory planning.
- Maintain quality and compliance. An exemption from 510(k) does not eliminate other applicable FDA requirements including the Quality Management System Regulation (QMSR), where applicable, or the need for appropriate manufacturing controls.
Understanding these requirements early helps OEMs make informed decisions about product development, regulatory planning and manufacturing.
Regulatory planning and manufacturing strategy are closely connected. Even when a device qualifies for a 510(k) exemption, it must still meet applicable safety, performance and quality requirements.
For MedTech OEMs, early manufacturing planning helps establish a clear path from development to commercial production. Key considerations include:
- Design and industrialization: Translating product requirements into a manufacturing-ready solution.
- Materials and processes: Selecting suitable components and establishing repeatable manufacturing processes.
- Testing and quality assurance: Defining appropriate verification activities and quality controls.
- Scalability: Preparing production to meet commercial demand while maintaining consistent quality.
Working with a manufacturing partner that brings multiple capabilities together can help OEMs coordinate these activities and prepare for serial production.
Changes in the regulatory landscape can create new opportunities, but successful market entry also depends on manufacturing readiness and an integrated approach to product development and production.
At SHL Healthcare, we bring together product development and manufacturing capabilities to support MedTech OEMs working on complex medical devices and advanced applications. Our integrated approach helps customers coordinate manufacturing requirements and prepare for scalable production.
As your All-In-One Manufacturing Partner, SHL Healthcare supports the journey from development to manufacturing with a focus on Precision, Partnership and Performance.
Planning Your Next Medical Device Project For The U.S. Market?
Let’s discuss how SHL Healthcare can support your manufacturing requirements.
Send us your request at: bd@shl-healthcare.com
Disclaimer: This article is for informational purposes only and does not constitute regulatory advice. Manufacturers should consult the FDA’s current guidance and applicable regulations to determine device-specific requirements.


Sorry, the comment form is closed at this time.